Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1613

1.

Alternatives to animal experimentation in basic research.

Gruber FP, Hartung T.

ALTEX. 2004;21 Suppl 1:3-31. Review.

PMID:
15586255
[PubMed - indexed for MEDLINE]
2.

The 3Rs and animal welfare - conflict or the way forward?

Rusche B.

ALTEX. 2003;20(Suppl 1):63-76. Review.

PMID:
14671703
[PubMed - indexed for MEDLINE]
4.

Do we need a "Chair of alternative methods", and where?

Wendel A.

ALTEX. 2002;19(2):64-8.

PMID:
12098011
[PubMed - indexed for MEDLINE]
Free Article
5.

[The origin of informed consent].

Mallardi V.

Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27. Italian.

PMID:
16602332
[PubMed - indexed for MEDLINE]
6.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
[PubMed - indexed for MEDLINE]
7.

Implementation and enforcement of the 3Rs principle in the field of transgenic animals used for scientific purposes. Report and recommendations of the BfR expert workshop, May 18-20, 2009, Berlin, Germany.

Kretlow A, Butzke D, Goetz ME, Grune B, Halder M, Henkler F, Liebsch M, Nobiling R, Oelgeschlaeger M, Reifenberg K, Schaefer B, Seiler A, Luch A.

ALTEX. 2010;27(2):117-34.

PMID:
21445538
[PubMed - indexed for MEDLINE]
8.

Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).

Lilienblum W, Dekant W, Foth H, Gebel T, Hengstler JG, Kahl R, Kramer PJ, Schweinfurth H, Wollin KM.

Arch Toxicol. 2008 Apr;82(4):211-36. doi: 10.1007/s00204-008-0279-9. Epub 2008 Mar 6.

PMID:
18322675
[PubMed - indexed for MEDLINE]
9.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
[PubMed - indexed for MEDLINE]
10.
11.

How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.

Kirkland D, Pfuhler S, Tweats D, Aardema M, Corvi R, Darroudi F, Elhajouji A, Glatt H, Hastwell P, Hayashi M, Kasper P, Kirchner S, Lynch A, Marzin D, Maurici D, Meunier JR, Müller L, Nohynek G, Parry J, Parry E, Thybaud V, Tice R, van Benthem J, Vanparys P, White P.

Mutat Res. 2007 Mar 30;628(1):31-55. Epub 2007 Jan 13.

PMID:
17293159
[PubMed - indexed for MEDLINE]
12.

[Procedures and methods of benefit assessments for medicines in Germany].

Bekkering GE, Kleijnen J.

Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25. German.

PMID:
19034813
[PubMed - indexed for MEDLINE]
13.

Anticancer Drug Development: The Way Forward.

Connors T.

Oncologist. 1996;1(3):180-181.

PMID:
10387985
[PubMed - as supplied by publisher]
Free Article
14.

New ways of insulin delivery.

Heinemann L.

Int J Clin Pract Suppl. 2011 Feb;(170):31-46. doi: 10.1111/j.1742-1241.2010.02577.x. Review.

PMID:
21323811
[PubMed - indexed for MEDLINE]
15.

Family pediatrics: report of the Task Force on the Family.

Schor EL; American Academy of Pediatrics Task Force on the Family.

Pediatrics. 2003 Jun;111(6 Pt 2):1541-71.

PMID:
12777595
[PubMed - indexed for MEDLINE]
16.

[Developments in the area of animal experiments in biomedical research].

Hendriksen CF.

Ned Tijdschr Geneeskd. 2006 Dec 30;150(52):2857-62. Review. Dutch.

PMID:
17319216
[PubMed - indexed for MEDLINE]
17.
18.

Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.

Lunsford LD, Flickinger JC, Larson D.

Oncologist. 1997;2(1):59-61.

PMID:
10388030
[PubMed - as supplied by publisher]
Free Article
19.

[Evaluation of authorised experiments on laboratory animals with regard to the aim of the research to be carried out, its scientific usefulness and its medical relevance].

Lindl T, Weichenmeier I, Labahn D, Gruber FP, Völkel M.

ALTEX. 2001;18(3):171-8. German.

PMID:
11565051
[PubMed - indexed for MEDLINE]
20.

Three Rs potential in the development and quality control of pharmaceuticals.

Hartung T.

ALTEX. 2001;18 Suppl 1:3-13.

PMID:
11854852
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk